• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴幼儿血管瘤患儿的生活质量:一项病例对照研究。

Quality of life in children with infantile hemangioma: a case control study.

作者信息

Wang Chuan, Li Yanan, Xiang Bo, Xiong Fei, Li Kai, Yang Kaiying, Chen Siyuan, Ji Yi

机构信息

Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, #37 Guo-Xue-Xiang, Chengdu, Sichuan Province, 610041, China.

Department of Child Health, West China Second University Hospital, Sichuan University, Sichuan Province, Chengdu, China.

出版信息

Health Qual Life Outcomes. 2017 Nov 16;15(1):221. doi: 10.1186/s12955-017-0772-z.

DOI:10.1186/s12955-017-0772-z
PMID:29145889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5689165/
Abstract

BACKGROUND

Infantile hemangioma (IH) is the most common vascular tumor in children. It is controversial whether IHs has effects on the quality of life (QOL) in patients of whom IH poses no threat or potential for complication. Thus, we conducted this study to evaluate the q QOL in patients with IH and find the predictors of poor QOL.

METHODS

The PedsQL 4.0 Genetic Core Scales and the PedsQL family information form were administered to parents of children with IH and healthy children both younger than 2-year-old. The quality-of-life instrument for IH (IH-QOL) and the PedsQL 4.0 family impact module were administered to parents of children with IH. We compared the PedsQL 4.0 Genetic Core Scales (GCIS) scores of the two groups. Multiple step-wise regression analysis was used to determine factors that influenced QOL in children with IH and their parents.

RESULTS

Except for physical symptom, we found no significant difference in GCIS between patient group and healthy group (P = 0.409). The internal reliability of IH-QOL was excellent with the Cronbach's alpha coefficient for summary scores being 0.76. Multiple step-wise regression analysis showed that the predictors of poor IH-QOL total scores were hemangioma size, location, and mother's education level. The predictors of poor FIM total scores were hemangioma location and father's education level. The predictors of poor GCIS total scores were children's age, hemangioma location and father's education level.

CONCLUSION

The findings support the feasibility and reliability of the Chinese version of IH-QOL to evaluate the QOL in children with IH and their parents. Hemangioma size, location and education level of mother are important impact factors for QOL in children with IH and their parents.

摘要

背景

婴儿血管瘤(IH)是儿童最常见的血管肿瘤。对于IH对无威胁或无并发症风险患者生活质量(QOL)是否有影响存在争议。因此,我们开展本研究以评估IH患者的生活质量并找出生活质量差的预测因素。

方法

对年龄小于2岁的IH患儿及健康儿童的父母使用儿童生活质量量表4.0遗传核心量表(PedsQL 4.0 Genetic Core Scales)和儿童生活质量量表家庭信息表。对IH患儿的父母使用IH生活质量量表(IH-QOL)和儿童生活质量量表4.0家庭影响模块。我们比较了两组的儿童生活质量量表4.0遗传核心量表(GCIS)得分。采用多元逐步回归分析确定影响IH患儿及其父母生活质量的因素。

结果

除身体症状外,我们发现患者组和健康组的GCIS无显著差异(P = 0.409)。IH-QOL的内部信度极佳,总分的Cronbach's α系数为0.76。多元逐步回归分析显示,IH-QOL总分低的预测因素为血管瘤大小、位置和母亲的教育水平。家庭影响模块(FIM)总分低的预测因素为血管瘤位置和父亲的教育水平。GCIS总分低的预测因素为儿童年龄、血管瘤位置和父亲的教育水平。

结论

研究结果支持中文版IH-QOL评估IH患儿及其父母生活质量的可行性和可靠性。血管瘤大小、位置及母亲的教育水平是影响IH患儿及其父母生活质量的重要因素。

相似文献

1
Quality of life in children with infantile hemangioma: a case control study.婴幼儿血管瘤患儿的生活质量:一项病例对照研究。
Health Qual Life Outcomes. 2017 Nov 16;15(1):221. doi: 10.1186/s12955-017-0772-z.
2
Influence of infantile hemangioma severity and activity on QoL of patients and their parents: A cross-sectional study.婴儿血管瘤的严重程度和活跃度对患者及其父母生活质量的影响:一项横断面研究。
Pediatr Dermatol. 2018 Sep;35(5):628-634. doi: 10.1111/pde.13599. Epub 2018 Jul 17.
3
Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas.婴幼儿血管瘤生活质量评估量表的制定与验证。
J Invest Dermatol. 2015 Jun;135(6):1533-1539. doi: 10.1038/jid.2015.18. Epub 2015 Jan 23.
4
The impact of pediatric nephrotic syndrome on parents' health-related quality of life and family functioning: an assessment made by the PedsQL 4.0 family impact module.小儿肾病综合征对父母健康相关生活质量和家庭功能的影响:采用儿童生活质量量表4.0家庭影响模块进行的评估
Saudi J Kidney Dis Transpl. 2015 Mar;26(2):285-92. doi: 10.4103/1319-2442.152420.
5
Social Impact of Facial Infantile Hemangiomas in Preteen Children.学龄前儿童面部婴幼儿血管瘤的社会影响
JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):13-9. doi: 10.1001/jamaoto.2015.2597.
6
Quality of life of children with spinal muscular atrophy and their caregivers from the perspective of caregivers: a Chinese cross-sectional study.从照顾者角度看脊髓性肌萎缩症患儿及其照顾者的生活质量:一项中国横断面研究
Orphanet J Rare Dis. 2021 Jan 6;16(1):7. doi: 10.1186/s13023-020-01638-8.
7
Burden of Infantile Hemangioma on Family: An International Observational Cross-Sectional Study.婴儿血管瘤对家庭的负担:一项国际观察性横断面研究。
Pediatr Dermatol. 2017 May;34(3):295-302. doi: 10.1111/pde.13133. Epub 2017 Apr 6.
8
Does treatment with propranolol affect quality of life in infantile hemangioma patients and their parents?普萘洛尔治疗会影响婴幼儿血管瘤患者及其父母的生活质量吗?
Pediatr Dermatol. 2019 Nov;36(6):958-960. doi: 10.1111/pde.13941. Epub 2019 Sep 30.
9
Parental experiences with propranolol versus oral corticosteroids for complicated infantile hemangioma, a retrospective questionnaire study.普萘洛尔与口服皮质类固醇治疗复杂婴儿血管瘤的家长体验:一项回顾性问卷调查研究
Eur J Dermatol. 2013 Nov-Dec;23(6):857-63. doi: 10.1684/ejd.2013.2176.
10
Factors influencing agreement between child self-report and parent proxy-reports on the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales.影响儿童自我报告与家长代理报告在儿童生活质量量表4.0(PedsQL)通用核心量表上一致性的因素。
Health Qual Life Outcomes. 2006 Aug 30;4:58. doi: 10.1186/1477-7525-4-58.

引用本文的文献

1
PHACE syndrome: looking backward and forward.PHACE综合征:回顾与展望。
Orphanet J Rare Dis. 2025 Jul 7;20(1):345. doi: 10.1186/s13023-025-03899-7.
2
Knowledge, attitudes, and practices on hemangioma among parents of infantile hemangioma patients in South China.中国南方婴幼儿血管瘤患者家长对血管瘤的认知、态度及行为
Sci Rep. 2025 May 2;15(1):15350. doi: 10.1038/s41598-025-00228-7.
3
Targeting ESM1 via SOX4 promotes the progression of infantile hemangioma through the PI3K/AKT signaling pathway.通过SOX4靶向ESM1可通过PI3K/AKT信号通路促进婴幼儿血管瘤的进展。
Precis Clin Med. 2024 Oct 9;7(4):pbae026. doi: 10.1093/pcmedi/pbae026. eCollection 2024 Dec.
4
Malignant and Benign Head and Neck Tumors of the Pediatric Age: A Narrative Review.儿童期头颈部良恶性肿瘤:一项叙述性综述
Curr Pediatr Rev. 2025;21(2):118-132. doi: 10.2174/0115733963258575231123043807.
5
Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents.婴幼儿血管瘤患儿接受普萘洛尔或阿替洛尔治疗后的学龄期儿童及其家长的心理健康状况。
Dermatology. 2024;240(2):216-225. doi: 10.1159/000536144. Epub 2024 Jan 16.
6
Validation of a Quality of Life Assessment Questionnaire for Patients with Infantile Hemangioma and Their Families - the IH-QOL-RO.婴儿血管瘤患者及其家庭生活质量评估问卷——IH-QOL-RO的验证
Maedica (Bucur). 2023 Jun;18(2):286-292. doi: 10.26574/maedica.2023.18.2.286.
7
Infantile hemangioma models: is the needle in a haystack?婴儿血管瘤模型:是大海捞针吗?
J Transl Med. 2023 May 6;21(1):308. doi: 10.1186/s12967-023-04144-0.
8
IADVL SIG Pediatric Dermatology (Academy) Recommendations on Hemangioma of Infancy (HOI).国际皮肤性病学会儿科皮肤病学(学会)关于婴儿血管瘤(HOI)的建议
Indian Dermatol Online J. 2023 Mar 3;14(2):172-186. doi: 10.4103/idoj.idoj_52_22. eCollection 2023 Mar-Apr.
9
Childhood cancer survivorship in China: An overview of the past two decades.中国儿童癌症生存状况:过去二十年概述。
Cancer Med. 2022 Dec;11(23):4588-4601. doi: 10.1002/cam4.4831. Epub 2022 May 22.
10
Health-Related Quality of Life in Children With Kaposiform Hemangioendothelioma.卡波西样血管内皮瘤患儿的健康相关生活质量
Front Pediatr. 2022 Feb 24;10:720611. doi: 10.3389/fped.2022.720611. eCollection 2022.

本文引用的文献

1
Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study.儿童多灶性肝血管瘤的临床特征与处理:一项回顾性研究。
Sci Rep. 2016 Aug 17;6:31744. doi: 10.1038/srep31744.
2
Topical Timolol Maleate Treatment of Infantile Hemangiomas.马来酸噻吗洛尔局部治疗婴幼儿血管瘤
Pediatrics. 2016 Sep;138(3). doi: 10.1542/peds.2016-0355. Epub 2016 Aug 15.
3
Oral atenolol therapy for proliferating infantile hemangioma: A prospective study.口服阿替洛尔治疗增殖期婴儿血管瘤:一项前瞻性研究。
Medicine (Baltimore). 2016 Jun;95(24):e3908. doi: 10.1097/MD.0000000000003908.
4
Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma.接受局部用噻吗洛尔治疗婴儿血管瘤的婴幼儿的不良事件
Pediatr Dermatol. 2016 Jul;33(4):405-14. doi: 10.1111/pde.12869. Epub 2016 May 31.
5
Safety of Propranolol Therapy for Severe Infantile Hemangioma.普萘洛尔治疗重症婴儿血管瘤的安全性
JAMA. 2016 Jan 26;315(4):413-5. doi: 10.1001/jama.2015.13969.
6
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.西罗莫司治疗复杂血管异常的疗效与安全性。
Pediatrics. 2016 Feb;137(2):e20153257. doi: 10.1542/peds.2015-3257. Epub 2016 Jan 18.
7
Diagnosis and Management of Infantile Hemangioma.婴幼儿血管瘤的诊断与治疗。
Pediatrics. 2015 Oct;136(4):e1060-104. doi: 10.1542/peds.2015-2485.
8
Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).评估口服普萘洛尔治疗婴儿血管瘤的疗效:一项比较血管瘤活动评分(HAS)与血管瘤严重程度评分(HSS)的前瞻性研究。
J Am Acad Dermatol. 2015 Aug;73(2):258-63. doi: 10.1016/j.jaad.2015.05.012.
9
A randomized, controlled trial of oral propranolol in infantile hemangioma.口服普萘洛尔治疗婴儿血管瘤的随机对照试验。
N Engl J Med. 2015 Feb 19;372(8):735-46. doi: 10.1056/NEJMoa1404710.
10
Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas.婴幼儿血管瘤生活质量评估量表的制定与验证。
J Invest Dermatol. 2015 Jun;135(6):1533-1539. doi: 10.1038/jid.2015.18. Epub 2015 Jan 23.